DYN Stock Analysis: Buy, Sell, or Hold?
DYN - Dyne Therapeutics, Inc. Common Stock
$23.64
0.22 (0.94%)
▲
5d:
+3.5%
30d:
+33.79%
90d:
+26.55%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 27, 2026
12d
Get Alerted When DYN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DYN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: DYN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: DYN is currently trading at $23.64, which is considered extended relative to its 30-day fair value range of $18.18 to $22.82.
Technical Outlook: Technically, DYN is in a uptrend. Immediate support is located at $20.43, while resistance sits at $24.60.
Market Sentiment: DYN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $38.25 (+61.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DYN is in a uptrend. Immediate support is located at $20.43, while resistance sits at $24.60.
Market Sentiment: DYN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $38.25 (+61.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.18 -
$22.82
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.8% below Wall St target ($38.25)
Trading Range Analysis
30-Day Trading Range
$18.18 -
$22.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.44
Resistance Level
$24.60
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.89
Wall Street Target
$38.25
(+61.8%)
Share & Embed Analysis
Last updated: July 13, 2026 8:12 PM ET
Data refreshes hourly during market hours. Next update: 9:12 PM
Data refreshes hourly during market hours. Next update: 9:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DYN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason P Rhodes
SELL
287956 shares
2026-04-22
Jason P Rhodes
SELL
274297 shares
2026-04-21
Jason P Rhodes
SELL
272049 shares
2026-04-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 62 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 67 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 59 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 49 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 54 HOLD |
Advanced DYN Option Strategies
Professional options setups generated by AI based on today's DYN price and gamma walls.